发明名称 |
Anvendelse af farmaceutiske præparater til behandling af neurodegenerative sygdomme |
摘要 |
Use of a cpd (A) that (partly) inhibits interaction between sequence (I) and transcription factors (TF) to prepare a compsn. for treating and/or preventing neurodegenerative disease is new. AGCCGCAAGTGACTCAGCGCG4C (I) Also new are: (1) recombinant virus having inserted in its genome at least one double-stranded nucleic acid (B) corresponding to the site of interaction of TF on DNA; and (2) pharmaceutical compsns. contg. (B) complexed with DEAE-dextran, nuclear proteins or lipids, either in crude form or incorporated into liposomes. |
申请公布号 |
DK0707644(T3) |
申请公布日期 |
2005.01.17 |
申请号 |
DK19940920987T |
申请日期 |
1994.06.27 |
申请人 |
AVENTIS PHARMA S.A. |
发明人 |
REVAH, FREDERIC;ROBERT, JEAN-JACQUES;MALLET, JACQUES |
分类号 |
C12N15/09;A61K31/70;A61K31/711;A61K35/76;A61K38/00;A61K48/00;A61P25/00;C07K14/82;C12N7/00;C12N7/01;C12N15/11;C12N15/113;C12N15/86;C12Q1/68;(IPC1-7):C12N15/11 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|